03.02.2005 16:02:00

Digirad to Present at the 2005 Merrill Lynch Global Pharmaceutical, Bi

Digirad to Present at the 2005 Merrill Lynch Global Pharmaceutical, Biotechnology, and Medical Device Conference


    Business Editors/Health/Medical Writers
    2005 Merrill Lynch Global Pharmaceutical, Biotechnology, and
    Medical Device Conference

    POWAY, Calif.--(BUSINESS WIRE)--Feb. 3, 2005--Digirad Corporation (Nasdaq:DRAD), a leader in providing solid-state imaging products and services to physician offices, hospitals and imaging centers, announced today that David Sheehan, President and CEO, will present at the 2005 Merrill Lynch Global Pharmaceutical, Biotechnology, and Medical Device Conference in New York at 2:00 p.m. local time (11:00 a.m. PT) on Wednesday, February 9.
    Digirad's presentation will be webcast live at http://www.wsw.com/webcast/ml32/drad and will be available for viewing for 14 days following the conference from the Investor Relations section of Digirad's website, www.digirad.com.

    About Digirad

    Digirad Corporation develops, manufactures and markets solid-state, digital gamma cameras to hospitals, imaging centers and physician offices. Digirad offers a comprehensive line of solid-state nuclear gamma cameras that can be used for the detection of many medical conditions including cardiovascular disease. Digirad believes that these imaging systems produce a high-quality image; due to their lightweight and compact design, they fit easily into small office spaces.
    Through its wholly owned subsidiaries, Digirad Imaging Solutions and Digirad Imaging Systems, Digirad also offers a comprehensive and mobile imaging leasing and services program for physicians who wish to perform nuclear cardiology procedures in their offices but do not have the patient volume, capital or resources to justify purchasing a gamma camera. Digirad Corporation, Digirad Imaging Solutions and Digirad Imaging Systems are headquartered in Poway, California. For more information, please visit www.digirad.com.
    Digirad(R) and Digirad Imaging Solutions(R) are registered trademarks of Digirad Corporation.

    DRADG

--30--SM/la*

CONTACT: Digirad Corporation Todd Clyde, 858-726-1600 tclyde@digirad.com or Lippert/Heilshorn & Associates Ina McGuinness or Bruce Voss, 310-691-7100 imcguinness@lhai.com

KEYWORD: CALIFORNIA INDUSTRY KEYWORD: MEDICAL DEVICES MEDICAL TRADESHOW CONFERENCE CALLS SOURCE: Digirad Corporation

Copyright Business Wire 2005

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 954,30 -0,50%